Glycaemic Control and Quality of Care in Type 2 Diabetes on NovoMix® 30 Previously Treated With Mixtard® Insulins
NCT00657319
·
clinicaltrials.gov ↗
COMPLETED
Status
3495
Enrollment
INDUSTRY
Sponsor class
Conditions
Diabetes
Diabetes Mellitus, Type 2
Interventions
DRUG:
biphasic insulin aspart 30
Sponsor
Novo Nordisk A/S